Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized Therapy
- PMID: 34787738
- DOI: 10.1245/s10434-021-11055-1
Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized Therapy
References
-
- Paulson KG, Park SY, Vandeven NA, Lachance K, Thomas H, Chapuis AG, et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78(3):457–63. https://doi.org/10.1016/j.jaad.2017.10.028 . - DOI - PubMed
-
- Harms KL, Healy MA, Nghiem P, Sober AJ, Johnson TM, Bichakjian CK, et al. Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol. 2016;23(11):3564–71. https://doi.org/10.1245/s10434-016-5266-4 . - DOI - PubMed
-
- Colunga A, Pulliam T, Nghiem P. Merkel cell carcinoma in the age of immunotherapy: facts and hopes. Clin Cancer Res. 2018;24:2035–43. https://doi.org/10.1158/1078-0432.CCR-17-0439 . - DOI - PubMed
-
- Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–100. https://doi.org/10.1126/science.1152586 . - DOI - PubMed - PMC
-
- Pietropaolo V, Prezioso C, Moens U. Merkel cell polyomavirus and Merkel cell carcinoma. Cancers (Basel). 2020. https://doi.org/10.3390/cancers12071774 . - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources